Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for healthcare industry professionals · Thursday, April 3, 2025 · 799,805,264 Articles · 3+ Million Readers

Stellix Announces Innovation-Focused Aspire 2025 Event to Accelerate Life Sciences Advancements in Greater Boston

Where biotech, AI, and innovation converge—join 150+ leaders at Stellix Aspire 2025.

A first look at Stellix’s Future Lab + exclusive panels on AI, biotech, and collaboration in the Boston life sciences ecosystem.

Opportunity at the intersection of technology and life science innovation has never been greater.”
— Jenn Azar, CEO of Stellix
FOXBOROUGH, MA, UNITED STATES, April 2, 2025 /EINPresswire.com/ -- Stellix is proud to announce Stellix Aspire 2025: Where Innovation Meets Aspiration, taking place on April 10, 2025, at the Stellix Corporate Headquarters in Foxborough, Massachusetts—just outside of Boston.

This exclusive event will bring together more than 150 life sciences leaders from the Greater Boston area and beyond, representing pharmaceutical, biotech, and technology companies. Attendees will explore outcomes made possible by cutting-edge strategies in AI, digital transformation, and life sciences innovation. Between sessions, guests will tour Stellix’s new, state-of-the-art Customer Experience Center (CEC) and Future Lab, where real-world transformation meets next-gen technology—showcasing partnerships with a dozen leading tech companies.

Key Event Highlights:

CEC Tours and Outcomes Lounge open at 1:00 PM

AI in Life Sciences Operations Panel (2:00 – 3:00 PM): Industry leaders will share perspectives on AI adoption within life sciences and strategies to realize its potential.

Fireside Chat on Patient-Centric Collaboration (4:00 – 4:45 PM): Leaders from MassBio and a dynamic rare disease patient advocate will explore the benefits of cross-industry collaboration and enhanced support for patients in need.

Keynote Address (6:30 PM): Jamie Metzl, renowned futurist and author of Superconvergence, will deliver a keynote on transformative opportunities at the intersection of AI, genetics, and biotechnology.

“Opportunity at the intersection of technology and life science innovation has never been greater,” said Jenn Azar, CEO of Stellix. “Stellix Aspire 2025 reflects our commitment to bringing the industry together for real and meaningful impact.”

Media are invited to attend in person for exclusive access to key speakers, behind-the-scenes tours of Stellix’s new innovation hub, and networking with top voices shaping Boston’s life sciences future.

For media inquiries or to request an onsite press pass, please contact:

Carrie Fraser
Senior Director, Corporate Marketing
contact@stellix.com

Carla Higham
Deene Strategic Partners
email us here

Powered by EIN Presswire

Distribution channels: Healthcare & Pharmaceuticals Industry

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Submit your press release